Related Experiment Video
Updated: Feb 24, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
954
Sex Difference Has No Effect on Survival in Pancreatic Cancer
1Department of Medical Oncology, Institute of Oncology, University of Istanbul, Capa, 34390 Istanbul, Turkey.
Indian Journal of Surgical Oncology
|February 23, 2026
Summary
This study found no significant difference in pancreatic cancer survival rates between men and women. Sex does not appear to impact overall survival in pancreatic cancer patients across all disease stages.
Area of Science:
- Oncology
- Cancer Research
- Clinical Significance of Sex in Cancer
Background:
- The clinical impact of sex on pancreatic cancer outcomes remains controversial.
- Previous studies have yielded conflicting results regarding sex-based differences in pancreatic cancer.
Purpose of the Study:
- To investigate the clinical significance of sex in pancreatic cancer patients.
- To determine if sex influences survival rates and clinical variables in pancreatic cancer.
Main Methods:
- Retrospective analysis of 334 pancreatic cancer patients.
- Assessment of sex distribution across different disease stages (local, locally advanced, metastatic).
- Evaluation of serum lactate dehydrogenase (LDH) levels and overall survival rates by sex.
Main Results:
- No significant difference in sex distribution across disease stages (p=0.9).
- Women with metastatic pancreatic cancer showed higher serum LDH levels than men (p=0.009).
- Overall survival rates were similar between sexes across all disease stages (metastatic p=0.2, locally advanced p=0.6, local p=0.09).
Conclusions:
- Sex was not found to significantly affect overall survival in pancreatic cancer patients.
- While higher LDH levels were observed in women with metastatic disease, this did not translate to survival differences.
- The findings suggest that sex is not a determining factor for survival in pancreatic cancer.
Related Concept Videos
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
Comparing the Survival Analysis of Two or More Groups
652
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
652

